Press Releases :: Nighthawk Biosciences, Inc. (SCPX)

Feb 17, 2017 7:00am EST

Heat Biologics Presents Immune Data on its HS-410 Phase 2 Bladder Cancer Trial at the Genitourinary Cancers Symposium

Feb 14, 2017 8:00am EST

Heat Biologics to Present at the Genitourinary Cancers Symposium

Jan 24, 2017 8:00am EST

Heat Biologics to Present at NobleCon13

Jan 05, 2017 8:00am EST

Heat Biologics to Present at Biotech Showcase 2017 Conference in San Francisco

Jan 04, 2017 8:00am EST

Heat Biologics Appoints Jeff Hutchins, Ph.D., as Chief Scientific Officer

Dec 06, 2016 8:20am EST

Heat Biologics Presents Topline HS-110/Nivolumab Combination Lung Cancer Results

Nov 30, 2016 5:28pm EST

Heat Biologics Presents Topline HS-410 Phase 2 Bladder Cancer Results at the Society of Urological Oncology Annual Meeting

Nov 17, 2016 7:00am EST

Heat Biologics to Present Topline HS-110/Nivolumab Combination Phase Ib Lung Cancer Results at the International Society for the Study of Lung Cancer Annual Meeting

Nov 16, 2016 7:00am EST

Heat Biologics to Present Topline HS-410 Phase II Bladder Cancer Results at the Society of Urological Oncology Annual Meeting

Nov 14, 2016 7:00am EST

Heat Biologics Presents ComPACT Preclinical Data at the Society for Immunotherapy of Cancer Annual Meeting

rss_feed News RSS